Individual psychoeducation program for inpatients with schizophrenia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates an individual psychoeducation program called PEPITS for inpatients diagnosed with schizophrenia and related disorders. The program is designed to be implemented by nurses during the early stages of hospitalization, aiming to enhance medication compliance and improve patient insight. By focusing on psychoeducation, the study hypothesizes that it will reduce relapse rates and enhance the overall quality of life for patients. The approach emphasizes the importance of therapeutic alliance and patient engagement in their treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 18 and 65 years
* Patient with a diagnosed and reported schizophrenic disorder announced :

  * Schizophrenia
  * Schizoaffective disorder
* Or a diagnosed and reported Delusional Disorder
* Express written consent by the participant after receiving information about the study
* Be able to communicate verbally
* Participant affiliated to a social security scheme

Exclusion Criteria:

* Pregnant or breastfeeding woman
* Patient who does not speak French
* Participation in a psycho-education group in the last 2 years
* Patient under legal protection or guardianship

Where it's running

• Service de psychiatrie
  Chinon, France Recruiting
• Service de psychiatrie
  La Roche-sur-Yon, France Recruiting
• Service de psychiatrie
  Rennes, France Recruiting
• Service de psychiatrie
  Sainte-Gemmes-sur-Loire, France Recruiting
• Service de psychiatrie
  Tours, France Recruiting
• Serrvice de Psychiatrie
  Blois, France Withdrawn

Study contacts

• Study coordinator: Arnaud CHESSE
• Email: A.CHESSE@chu-tours.fr
• Phone: +33(0)2.34.37.89.68

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Lumateperone to improve motivation in patients with schizophrenia and psychosis

  This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.

  Recruiting Phase 3 Louisiana State University Health Sciences Center Shreveport · Shreveport, Louisiana · NCT06482554

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• XEP527 in stable schizophrenia: safety and how it behaves in the body

  This small, early-stage study tests the safety and how XEP527 behaves in people with stable schizophrenia who are on a single antipsychotic.

  Recruiting Phase 1 Novartis · Bentonville, Arkansas · NCT07908680

• Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations

  This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.

  Recruiting Ciusss de L'Est de l'Île de Montréal · Montreal, Quebec · NCT07902518

• Quality of life and safety in quetiapine use for schizophrenia or bipolar disorder

  This study looks at how patients with schizophrenia or bipolar disorder feel and stay safe when treated with quetiapine alone or with other antipsychotics.

  Recruiting Bosnalijek D.D · Sarajevo · NCT07858565

• Neuronavigated rTMS for treatment-resistant auditory hallucinations

  We are testing whether personalized neuronavigated inhibitory rTMS can reduce persistent auditory verbal hallucinations in adults who don’t respond to medication.

  Recruiting Psychiatric University Hospital, Zurich · Zurich · NCT07856368

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.